Gene expression profiles in murine influenza pneumonia

Journal of Innate Immunity

Volumn 1, Issue 4, 2009, Pages 366-375

  Dessing, Mark C ^a,b   Van Der Sluijs, Koenraad F ^a   Spek, C Arnold ^a   Van Der Poll, Tom ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Gene expression; Influenza pneumonia, murine; Multiplex ligation dependent probe amplification

Indexed keywords

CD150 ANTIGEN; CHEMOKINE; CYTOKINE; MESSENGER RNA; TOLL LIKE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOTTING; CELL ADHESION; CONTROLLED STUDY; FIBRINOLYSIS; GENE EXPRESSION; HOMEOSTASIS; INFLUENZA; INFLUENZA VIRUS A; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE REPAIR; TRACHEA;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; LEUKOCYTES; LUNG; MALE; MICE; MICE, INBRED C57BL; PNEUMONIA, VIRAL; TRACHEA;

EID: 77953381259     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000167961     Document Type: Article

References (50)

1. Murphy BR, Webster RG: Orthomyxoviruses; in Fields BN, Knipe DM, Howley PM (eds): Fields Virology, ed 3. Philadelphia, Lippincott-Raven, 1996, p 1407.
2. Treanor JJ: Orthomyxoviridae: influenza virus; in Mandell GL, Bennett JE, Dolin, R (eds): Principles and Practice of Infectious Diseases, ed 5. New York, Churchill Livingston, 2000, pp 1834-1835.
3. Ronni T, Sareneva T, Pirhonen J, Julkunen I: Activation of IFN-alpha, IFN-gamma, MxA, and IFN regulatory factor 1 genes in influenza A virus-infected human peripheral blood mononuclear cells. J Immunol 1995; 154: 2764-2774.
4. Tong HH, Long JP, Li D, DeMaria TF: Alteration of gene expression in human middle ear epithelial cells induced by influenza A virus and its implication for the pathogenesis of otitis media. Microb Pathog 2004; 37:193- 204.
5. Julkunen I, Sareneva T, Pirhonen J, Ronni T, Melen K, Matikainen S: Molecular patho-genesis of influenza A virus infection and virus-induced regulation of cytokine gene expression. Cytokine Growth Factor Rev 2001; 12: 171-180.
6. Guillot L, Le Goffic R, Bloch S, et al: Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J Biol Chem 2005; 280:5571-5580.
7. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C: Innate antiviral responses by means of TLR7-mediated recognition of single-stranded R NA. Science 2004; 303: 1529- 1531.
8. Lund JM, Alexopoulou L, Sato A, et al: Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci USA 2004; 101:5598-5603.
9. Miettinen M, Sareneva T, Julkunen I, Mati-kainen S: IFNs activate toll-like receptor gene expression in viral infections. Genes Immun 2001; 2: 349-355.
10. Lee RM, White MR, Hartshorn KL: Influenza a viruses upregulate neutrophil toll-like receptor 2 expression and function. Scand J Immunol 2006; 63:81-89.
11. Visseren FL, Bouwman JJ, Bouter K P, Die-persloot RJ, de Groot PH, Erkelens DW: Pro-coagulant activity of endothelial cells after infection with respiratory viruses. Thromb Haemost 2000; 84: 319-324.
12. Bouwman JJ, Visseren FL, Bosch MC, Bouter KP, Diepersloot RJ: Procoagulant and inflammatory response of virus-infected monocytes. Eur J Clin Invest 2002; 32: 759- 766.
13. Keller TT, van der Sluijs KF, de Kruif MD, et al: Effects on coagulation and fibrinolysis induced by influenza in mice with a reduced capacity to generate activated protein C and a deficiency in plasminogen activator inhibitor type 1. Circ Res 2006; 99:1261-1269.
14. Sakai S, Mantani N, Kogure T, Ochiai H, Shimada Y, Terasawa K: Gene expression of cell surface antigens in the early phase of murine influenza pneumonia determined by a cDNA expression array technique. Mediators In-flamm 2002; 11:359-361.
15. Zhang H, Su YA, Hu P, et al: Signature patterns revealed by microarray analyses of mice infected with influenza virus A and Streptococcus pneumoniae. Microbes Infect 2006; 8:2172-2185.
16. Engler A, Roy S, Sen CK, Padgett DA, Sheridan JF: Restraint stress alters lung gene expression in an experimental influenza A viral infection. J Neuroimmunol 2005; 162: 103-111.
17. Xu W, Zheng S, Goggans TM, et al: Cystic fibrosis and normal human airway epithelial cell response to influenza a viral infection. J Interferon Cytokine Res 2006; 26:609-627.
18. Kawada J, Kimura H, Kamachi Y, et al: Analysis of gene-expression profiles by oligonu-cleotide microarray in children with influenza. J Gen Virol 2006; 87:1677-1683.
19. Diaz-Mitoma F, Alvarez-Maya I, Dabrowski A, et al: Transcriptional analysis of human peripheral blood mononuclear cells after influenza immunization. J Clin Virol 2004; 31: 100-112.
20. Cheung CY, Poon LL, Ng IH, et al: Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis. J Virol 2005; 79: 7819-7826.
21. van der Sluijs KF, van elden LJ, Arens R, et al: Enhanced viral clearance in interleukin-18 gene-deficient mice after pulmonary infection with influenza A virus. Immunology 2005; 114:112-120.
22. van der Sluijs KF, van Elden LJ, Xiao Y, et al: IL-12 deficiency transiently improves viral clearance during the late phase of respiratory tract infection with influenza A virus in mice. Antiviral Res 2006; 70: 75-84.
23. van Elden LJ, Nijhuis M, Schipper P, Schuur-man R, van Loon AM: Simultaneous detection of influenza viruses A and B using realtime quantitative PCR. J Clin Microbiol 2001; 39:196-200.
24. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G: Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002; 30:e57.
25. Spek CA, Verbon A, Aberson H, et al: Treatment with an anti-CD14 monoclonal antibody delays and inhibits lipopolysaccharide-induced gene expression in humans in vivo. J Clin Immunol 2003; 23:132-140.
26. Maris NA, de Vos AF, Dessing MC, et al: An-tiinflammatory effects of salmeterol after inhalation of lipopolysaccharide by healthy volunteers. Am J Respir Crit Care Med 2005; 172:878-884.
27. Abruzzo LV, Lee KY, Fuller A, et al: Validation of oligonucleotide microarray data using microfluidic low-density arrays: a new statistical method to normalize real-time RT-PCR data. Biotechniques 2005; 38: 785- 792.
28. Dessing MC, van der Sluijs KF, Florquin S, Akira S, van der Poll T: Toll-like receptor2 does not contribute to host response during postinfluenza pneumococcal pneumonia. Am J Respir Cell Mol Biol 2006; 36:609-614.
29. van der Sluijs KF, van Elden LJ, Nijhuis M, et al: Involvement of the platelet-activating factor receptor in host defense against Streptococcus pneumoniae during postinfluenza pneumonia. Am J Physiol Lung Cell Mol Physiol 2006; 290:L194-L199.
30. Dawson TC, Beck MA, Kuziel WA, Henderson F, Maeda N: Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus. Am J Pathol 2000; 156: 1951-1959.
31. Wareing MD, Lyon AB, Lu B, Gerard C, Sar-awar SR: Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infect ion in mice. J Leukoc Biol 2004; 76: 886- 895.
32. Hennet T, Ziltener HJ, Frei K, Peterhans E: A kinetic study of immune mediators in the lungs of mice infected with influenza A virus. J Immunol 1992; 14 9 : 932-939.
33. van der Sluijs KF, van Elden L, Nijhuis M, et al: Toll-like receptor 4 is not involved in host defense against respiratory tract infection with Sendai virus. Immunol Lett 2003; 89: 201-206.
34. Bowie AG, Haga IR: The role of Toll-like receptors in the host response to viruses. Mol Immunol 2005; 42:859-867.
35. Seki M, Yanagihara K, Higashiyama Y, et al: Immunokinetics in severe pneumonia due to influenza virus and bacteria coinfection in mice. Eur Respir J 2004; 24:143-149.
36. Ritter M, Mennerich D, Weith A, Seither P: Characterization of Toll-like receptors in primary lung epithelial cells: strong impact of the TLR3 ligand poly(I:C) on the regulation of Toll-like receptors, adaptor proteins and inflammatory response. J Inflamm (Lond) 2005; 2: 16.
37. Levi M, van der Poll T, Buller HR: Bidirectional relation between inflammation and coagulation. Circulation 2004; 109:2698- 2704.
38. Rijneveld AW, Florquin S, Bresser P, et al: Plasminogen activator inhibitor type-1 deficiency does not influence the outcome of murine pneumococcal pneumonia. Blood 2003; 102:934-939.
39. Renckens R, Roelofs JJ, Bonta PI, et al: Plas-minogen activator inhibitor type 1 is protective during severe Gram-negative pneumonia. Blood 2006; 109:1593-1601.
40. Sheppard D: Functions of pulmonary epithelial integrins: from development to disease. Physiol Rev 2003; 83: 673-686.
41. Herard AL, Pierrot D, Hinnrasky J, et al: Fi-bronectin and its alpha 5 beta 1-integrin receptor are involved in the wound-repair process of airway epithelium. Am J Physiol 1996; 271:L726-L733.
42. Yeo SJ, Kim SJ, Kim JH, Lee HJ, Kook YH: Influenza A virus infection modulates the expression of type IV collagenase in epithelial cells. Arch Virol 1999; 144: 1361-1370.
43. Collier IE, Wilhelm SM, Eisen AZ, et al: H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single me-talloprotease capable of degrading basement membrane collagen. J Biol Chem 1988; 263: 6579- 6587.
44. Greenlee KJ, Corry DB, Engler DA, et al: Pro-teomic identification of in vivo substrates for matrix metalloproteinases 2 and 9 reveals a mechanism for resolution of inflammation. J Immunol 2006; 177: 7312-7321.
45. Wassell J: Haptoglobin: function and polymorphism. Clin Lab 2000; 46: 547-552.
46. Peper RL, van Campen H: Tumor necrosis factor as a mediator of inflammation in influenza A viral pneumonia. Microb Pathog 1995; 19: 175-183.
47. Swiergiel AH, Smagin GN, Johnson LJ, Dunn AJ: The role of cytokines in the behavioral responses to endotoxin and influenza virus infection in mice: effects of acute and chronic administration of the interleukin-1-recep-tor antagonist (IL-1ra). Brain Res 1997; 776: 96-104.
48. Graham MB, Dalton DK, Giltinan D, Braci-ale VL, Stewart TA, Braciale TJ: Response to influenza infection in mice with a targeted disruption in the interferon gamma gene. J Exp Med 1993; 178: 1725-1732.
49. Pauligk C, Nain M, Reiling N, Gemsa D, Kaufmann A: CD14 is required for influenza A virus-induced cytokine and chemokine production. Immunobiology 2004; 209:3- 10.
50. Dessing MC, Van der Sluijs KF, Florquin S, Van der Poll T: CD14 plays a limited role during influenza virus infection in vivo. Immun Lett 2007;113:47-51.